NICE have just approved the new treatment, which could slow down progression for multiple myeloma patients
The drug is the first take-at-home tablet to be approved and will help patients live more ‘normal’ lives, without the side-effects of chemotherapy
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
